Submitted by: Submitted by KavinRichard9995
Views: 10
Words: 539
Pages: 3
Category: Business and Industry
Date Submitted: 11/30/2015 02:09 AM
Hexa Reports
Market Research Reports and Insightful Company Profiles
Global HER2-Negative Breast Cancer Market Size
and Share, Growth, Market Price, Analysis, Forecast
and Overview 2015 - 2019
HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is
expressed less in the tumor. According to the American Society of Clinical Oncology, most of the
patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast
cancer patients can also be hormone receptor positive (HR+). The HER2 protein is found on the outer
surface of the breast cells, and the hormone receptors are found inside breast cells. The cancers that
have detectable hormone receptors are known as HR+ breast cancer, and those with HER2-negative
have a low level of HER2 gene or the HER2 protein. HER2-negative breast cancer can also be HR+ and
then the most preferred therapy is hormone therapy. These patients can be treated with chemotherapy
or targeted therapy to improve their condition.
Browse Detail Report With TOC @ http://www.hexareports.com/report/global-her2-negative-breastcancer-market/details
Covered in this report
This report covers the present scenario and the growth prospects of the global HER2-negative breast
cancer market for the period 2015-2019. To calculate the market size, the report considers revenue
generated from the sales of various off-label and branded drugs and the expected launch of drug
candidates intended to be used in the treatment of HER2-negative breast cancer.
Table Of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Hexa Reports
Market Research Reports and Insightful Company Profiles
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
Request A Sample copy of This Report @ http://www.hexareports.com/sample/50091
PART 04: Introduction
Key market highlights
PART 05: Market landscape...